Erratum: EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas (Clinical Cancer Research (2018) 24 (6548–6555) DOI: 10.1158/1078-0432.CCR-18-1541)

Susan E. Jorge, Antonio R. Lucena-Araujo, Hiroyuki Yasuda, Zofia Piotrowska, Geoffrey R. Oxnard, Deepa Rangachari, Mark S. Huberman, Lecia V. Sequist, Susumu S. Kobayashi, Daniel B. Costa

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original version of this article (1), there is an error in the first paragraph of the Results section and in Figs. 1 and 2: The A767-V769dupASV representative EGFR exon 20 mutation was misspelled. The error has been corrected in the latest onlineHTMLand PDF versions of the article. The authors regret this error.

Original languageEnglish
Pages (from-to)2277
Number of pages1
JournalClinical Cancer Research
Volume26
Issue number9
DOIs
Publication statusPublished - 2020 May 1

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Erratum: EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas (Clinical Cancer Research (2018) 24 (6548–6555) DOI: 10.1158/1078-0432.CCR-18-1541)'. Together they form a unique fingerprint.

Cite this